Kevin Lynn

DMX Corp. Ltd. provides solutions for treatment and destruction of hazardous wastes, together with contaminated site remediation technologies. The company operates its business through four segments: Chemical Collection and Recycling, Waste Destruction, Corporate and Other Operations. The Chemical Collection and Recycling segment engages in the collection, processing, recycling and sale of chemicals, paints and oils. The Waste Destruction segment engages in the collection, processing and destruction of hazardous waste. The Corporate segment engages in the corporate overheads. The Other Operations segment engages in the consulting and project business units. It also provides services in the areas of consultancy, project management, fixation and encapsulation, treatment and destruction of hazardous waste and contaminated site remediation. The company was founded in 1985 and is headquartered in Sydney, Australia.

Sinovus Mining Ltd. operates as a junior resource company. It engages in the evaluation of current and prospective investments and projects, and ongoing reporting of existing investments. The company was founded on August 4, 2006 and is headquartered in Sydney, Australia.

Hunter Immunology Ltd. operates as a biotechnology company. It develops immune modulators for treatment of respiratory diseases. The company was founded by Phillip Comans in 2003 and is headquartered in Victoria, Australia.

Licella Holdings Ltd. engages in the transformation of biomass and other organic based material into a biocrude oil which can be refined to advanced biofuels and biochemicals. It offers the hydrothermal upgrading platform, the Cat-HTR™ (Catalytic Hydrothermal Reactor) which can rapidly and economically transform a wide range of biomass, waste, and industry residues into biocrude to produce biofuels and renewable chemicals. The company was founded in 2007 and is headquartered in North Sydney, Australia.

Granite Power Ltd. develops patented heat conversion technology. It offers design, delivery, installation, commissioning, operation, and ongoing maintenance. The company is headquartered in Sydney, Australia.

Mariposa Health Ltd. develops and manufactures pharmaceutical products. Its products include TA-270, for the treatment of COPD and HI-164, respiratory vaccine. The company was founded on September 12, 2010 and is headquartered in Bilgola Plateau, Australia.

Precious Metals Investments Ltd. is a private company based in Sydney, Australia. The Australian company was founded in 2010 by Charles David Straw. Charles David Straw has been the CEO since 2010.

Mariposa Health, Inc. operates as a development stage company which engages in pharmaceutical research and development activities. The company was founded on June 23, 2014 and is headquartered in La Jolla, CA.